*These statements have not been evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
BLIS Technologies Ltd (NZX:BLT) is pleased to advise that it has received a written acknowledgement from Food Standards Australia New Zealand (‘FSANZ’) that its new probiotic, BLIS M18™ is not ...
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription. Blis Technologies has engaged lawyers after one ...
* CO'S ORAL PROBIOTIC BLIS M18 OBTAINS GRAS STATUS ENABLING THE PROBIOTIC TO BE INCLUDED AS INGREDIENT IN FOOD PRODUCTS WITHIN U.S. Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results